Glycosylated Hemoglobin Test Reagent (HbA1c)
Overview of HbA1c
HbA1c overview glycosylated hemoglobin (HbA1c) is the product of
the combination of hemoglobin in human red blood cells and sugars
in serum. The combination of blood glucose and hemoglobin to
produce glycosylated hemoglobin is an irreversible reaction. The
occurrence of the reaction is proportional to the concentration of
blood glucose, and can be maintained for about 120 days. Therefore,
the detection of glycosylated hemoglobin can reflect the blood
glucose control of patients in recent 8-12 weeks.
HbA1c performance index
| Detection range | sample size | Sample type | Test time |
| 3％~14％ | 10μl | Whole Blood | 15min |
Clinical significance of HbA1c
- Early screening and diagnosis of diabetes mellitus
- Effect evaluation of blood glucose control program
- Prediction of chronic complications of diabetes
- Differential diagnosis between stress hyperglycemia and diabetes
mellitus
- Diagnosis and treatment monitoring of gestational diabetes mellitus
(GDM)
| Glycated hemoglobin control objectives | Adapt to the crowd |
| <6% | ① There were no adverse reactions such as hypoglycemia and weight
gain; ② No need for hypoglycemic drug intervention;③Diabetes
mellitus complicated with pregnancy; ④Diabetes mellitus found
during pregnancy |
| <6.5% | ① <65 years old, no diabetes complications and severe
concomitant diseases. ②Plan for gestational diabetes mellitus |
| <7% | ① Patients under 65 years old were treated with insulin; ② Patients
over 65 years old, without hypoglycemia risk, good organ function,
and survival time > 15 years; ③Planned insulin treatment for
gestational diabetes mellitus |
| ≤7.5% | Patients with cardiovascular disease or high risk of cardiovascular
disease |
| <8% | The patients were over 65 years old and the expected survival time
was 5-15 years |
| <9% | ① Patients over 65 years old or with malignant tumor have an
expected survival time of less than 5 years; ② High risk group of
hypoglycemia; ③ Those who are difficult to carry out the treatment
plan, such as mental or intellectual or visual impairment, poor
medical conditions, etc |
Application Department
Cardiology, laboratory, emergency, ICU, oncology,
Nephrology,Pediatrics, endocrinology, gynecology, geriatrics,
respiratory, thoracic surgery,Gastroenterology, Urology, etc
Clinical comparison of HbA1c
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.
